Quality of life after solid organ transplantation

Transplantation Reviews

Volumn 15, Issue 3, 2001, Pages 156-164

  Whiting, James F ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FUTUROLOGY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEASUREMENT; MEDICAL LITERATURE; MEDICAL RESEARCH; ORGAN TRANSPLANTATION; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 0035174828     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1053/trre.2001.24500     Document Type: Article

References (60)

1. The hierarchy of patient outcomes
2. Quality of life studies: Definitions and conceptual issues
3. The quality of life in renal transplantation-a prospective study
4. Treatment strategies for insulin-dependent diabetics with ESRD: A cost-effectiveness decision analysis model
5. A study of the quality of life and cost-utility of renal transplantation
6. A methodological comparison of health utility scores following renal transplantation
7. Measurements in clinical trials: Choosing the right approach
8. Measuring health state preferences and utilities: Rating scale, time trade-off, and standard gamble techniques
9. A new facility for the measurement of health-related quality of life
10. A guide to the economic analysis of clinical practices
11. The sickness impact profile: Development and final revision of a health status measure
12. Measuring health status; a new tool for clinicians and epidemiologists
13. The MOS 36-item short-form health survey (SF-36)
14. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the medical outcomes study
15. The MOS 36-item short-form health survey (SF-36), II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
16. Disease-specific questionnaire for patients with a renal transplant
17. A self-administered quality of life questionnaire for renal transplant recipients
18. Changes in quality of life after liver transplantation among adults
19. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease
20. Health-related quality of life in long-term survivors of pediatric liver transplantation
21. How to develop and validate a new health-related quality of life instrument
22. Quality of life: Statistical issues and analysis
23. Quality of life and antihypertensive therapy in men: A comparison of Captopril with Enalapril
24. Does transplantation produce quality of life benefits?
25. Studying the quality of life after organ transplantation: Research problems and solutions
26. Post kidney transplant quality of life prediction models
27. Clinical determinants of health-related quality of life in recipients of solid organ transplants
28. Predictors of quality of life and adjustment after lung transplantation
29. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival
30. Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy
31. Pancreas transplantation: Results and indications
32. Long-term effects of pancreatic transplantation on diabetic neuropathy
33. Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease
34. Impact of pancreas transplantation on diabetic secondary complications and quality of life
35. Quality of life after pancreas transplantation: A review
36. A prospective study of changes in quality of life reported by diabetic recipients of kidney-only and pancreas-kidney allografts
37. Improvement in quality of life reported by diabetic recipients of kidney-only and pancreas kidney allografts
38. The analysis of benefit and risk of combined pancreatic and renal transplantation versus renal transplantation alone
39. Long-term metabolic and quality of life results with pancreatic renal transplantation in insulin dependent diabetes mellitus
40. Rehabilitation and quality of life in diabetic patients after successful pancreas-kidney transplantation
41. Quality of life after successful pancreas kidney transplantation
42. Quality of life in type 1 (insulin-dependent) diabetic patients prior to and after pancreas and kidney transplantation in relation to organ function
43. Evaluation of the quality of life of patients with insulin-dependent diabets mellitus before and after organ transplantation with the SF-36 Health Survey
44. Quality of life in diabetic patients prior to or after pancreas transplantation in relation to organ function
45. Quality of life after combined kidney pancreas or kidney transplantation in diabetic patients with end-stage renal disease
46. Comparison of quality of life between pancreas-kidney and kidney transplant recipients: 1-year followup
47. One-year change in quality-of-life profiles in patients receiving pancreas and kidney transplants
48. Comparison before and after transplantation of pancreas kidney and pancreas kidney with loss of pancreas: A prospective controlled quality of life study
49. The quality of life in renal transplantation-a prospective study
50. Cost-utility analysis of living-donor kidney transplantation followed by pancreas transplantation versus simultaneous pancreas-kidney transplantation
51. Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: A theoretical analysis
52. Cost-utility of lung transplantation: A pilot study
53. Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy
54. Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation
55. Changes in quality of life following conversion from CyA to FK506 in orthotopic liver transplant patients
56. The effect of immunosuppressive drugs on quality of life after renal transplantation
57. Quality of life after heart transplantation in patients assigned to doube-or triple-drug therapy
58. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression
59. Quality of life with an implanted left ventricular assist device